Found: 31
Select item for more details and to access through your institution.
The Age of Cannabis Has Arrived: Issues for Older Adults.
- Published in:
- Psychiatric Times, 2021, v. 38, n. 3, p. 18
- By:
- Publication type:
- Article
Understanding and Managing Agitation Associated With Dementia.
- Published in:
- Psychiatric Times, 2019, v. 36, n. 12, p. 28
- By:
- Publication type:
- Article
Building a Better Older Brain.
- Published in:
- Psychiatric Times, 2017, v. 34, n. 1, p. 1
- By:
- Publication type:
- Article
Caring for the Dementia Caregiver: Ways To Identify and Reduce Burden.
- Published in:
- Psychiatric Times, 2007, n. 2, p. 15
- By:
- Publication type:
- Article
Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care: Intervention Trial.
- Published in:
- Research in Gerontological Nursing, 2021, v. 14, n. 5, p. 225, doi. 10.3928/19404921-20210825-02
- By:
- Publication type:
- Article
Interventions to Enhance Empathy and Person-Centered Care for Individuals With Dementia: A Systematic Review.
- Published in:
- Research in Gerontological Nursing, 2020, v. 13, n. 3, p. 158, doi. 10.3928/19404921-20191028-01
- By:
- Publication type:
- Article
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077312
- By:
- Publication type:
- Article
Applying Implementation Frameworks to Health IT Development in Dementia Care: Lessons from the CareHeroes Project.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 1, doi. 10.1002/alz.082157
- By:
- Publication type:
- Article
Pilot trial of Dronabinol adjunctive treatment of agitation in Alzheimer's disease (THC‐AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.064983
- By:
- Publication type:
- Article
Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 1, p. 261, doi. 10.1002/alz.12651
- By:
- Publication type:
- Article
The Effects of Multiple Doses of Lomecel‐B, Longeveron' s Cell‐based Therapy, on Alzheimer's disease: Study Design and Rationale of this Phase 2a Multi‐ center Clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.067168
- By:
- Publication type:
- Article
Safety and efficacy of Lomecel‐B in patients with mild Alzheimer's disease: Results of a double‐blinded, randomized, placebo‐controlled phase 1 clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057581
- By:
- Publication type:
- Article
Identification of empathic communication behaviors for enhancement of person center care: A blueprint.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.050298
- By:
- Publication type:
- Article
Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (THC‐AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052594
- By:
- Publication type:
- Article
Clinical evaluation of allogeneic mesenchymal stem cells for Alzheimer's disease: Human/Human trials: Inflammation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046634
- By:
- Publication type:
- Article
Effects of a combined transcranial magnetic stimulation (TMS) and cognitive training intervention in patients with Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 4, p. 641, doi. 10.1016/j.jalz.2019.08.197
- By:
- Publication type:
- Article
P2‐039: PROGRESS OF THE PHASE I CLINICAL TRIAL TO EVALUATE LONGEVERON ALLOGENEIC MESENCHYMAL STEM CELLS (LMSCS) AS A POTENTIAL THERAPEUTIC FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P586, doi. 10.1016/j.jalz.2019.06.1261
- By:
- Publication type:
- Article
TREATMENT WITH MEMANTINE AND A CHOLINESTERASE INHIBITOR REDUCES AGITATION IN PATIENTS WITH MODERATE TO SEVERE ALZHEIMER’S DISEASE AND BEHAVIORAL DISTURBANCES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P825, doi. 10.1016/j.jalz.2016.06.1678
- By:
- Publication type:
- Article
Dextromethorphan/quinidine (AVP-923) for treatment of agitation in patients with Alzheimer’s disease: Analysis of week 10 results for patients treated only with AVP-923 versus patients receiving only placebo (NCT01584440).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P291, doi. 10.1016/j.jalz.2015.07.397
- By:
- Publication type:
- Article
Dextromethorphan/quinidine (AVP-923) phase 2 study for treatment of agitation in Alzheimer’s disease: Comparing the enrolled agitation sample with the international psychogeriatric association definition of agitation in cognitive disorders (NCT01584440)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P751, doi. 10.1016/j.jalz.2015.06.1675
- By:
- Publication type:
- Article
Detection of ligand bound to beta amyloid in the lenses of human eyes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P173, doi. 10.1016/j.jalz.2014.04.184
- By:
- Publication type:
- Article
New Frontiers in the Treatment and Management of Alzheimer's Disease: Expert Perspectives on the Role of Emerging Therapies.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 2, p. 15
- By:
- Publication type:
- Article
Unique trans-kingdom microbiome structural and functional signatures predict cognitive decline in older adults.
- Published in:
- GeroScience, 2023, v. 45, n. 5, p. 2819, doi. 10.1007/s11357-023-00799-1
- By:
- Publication type:
- Article
From Cicero to Cohen: Developmental Theories of Aging, From Antiquity to the Present.
- Published in:
- Gerontologist, 2014, v. 54, n. 1, p. 30, doi. 10.1093/geront/gnt032
- By:
- Publication type:
- Article
Selling Depression to the Oversold.
- Published in:
- 1999
- By:
- Publication type:
- Book Review
Book reviews.
- Published in:
- 1998
- By:
- Publication type:
- Book Review
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
- Published in:
- JAMA Neurology, 2018, v. 75, n. 9, p. 1114, doi. 10.1001/jamaneurol.2018.0894
- By:
- Publication type:
- Article
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density.
- Published in:
- JAMA Neurology, 2015, v. 72, n. 3, p. 287, doi. 10.1001/jamaneurol.2014.4144
- By:
- Publication type:
- Article
Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2015, v. 30, n. 8, p. 738, doi. 10.1177/1533317513520214
- By:
- Publication type:
- Article
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Group therapy in older adults.
- Published in:
- Current Psychiatry Reports, 2009, v. 11, n. 1, p. 27, doi. 10.1007/s11920-009-0005-1
- By:
- Publication type:
- Article